Carotenoid lutein protects the kidney against cisplatin-induced acute renal failure

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 32, Issue 1, 2013, Pages 21-28

  Sindhu, Edakkadath R ^a   Kuttan, Ramadasan ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antioxidant enzymes; Kidney function; Lipid peroxidation; Nephroprotection; Nephrotoxicity; Oxidative stress

Indexed keywords

CATALASE; CISPLATIN; CREATININE; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UREA; XANTHOPHYLL;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW CELL; CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BONE MARROW CELLS; CAROTENOIDS; CATALASE; CISPLATIN; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; INJECTIONS; KIDNEY; LIPID PEROXIDATION; LUTEIN; MALONDIALDEHYDE; MICE; SUPEROXIDE DISMUTASE;

MUS;

EID: 84878465785     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.2013004933     Document Type: Article

References (36)

1. Lorenzo Y, Azqueta A, Luna L, Bonilla F, Dominguez G, Collins AR. The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells. Carcinogenesis. 2009;30:308-314.
2. Thurnham DL. Carotenoids: function and fallacies. Proc Nutr Soc. 1994;53: 77-87.
3. Sindhu ER, Preethi KC, Kuttan R. Antioxidant activity of carotenoid lutein in vitro and in vivo. Indian J Exp Biol. 2010;48:843-8.
4. Ojima F, Sakamoto H, Ishiguro Y, Terao J. Consumption of carotenoids in photosensitized oxidation of human plasma and plasma low-density lipoprotein. Free Radic Biol Med. 1993;15:377-4.
5. Ribaya-Mercado JD, Blumberg JB. Lutein and zeaxanthin and their potential roles in disease prevention. JACN. 2004; 23(6):567S-587S.
6. Sindhu ER, Firdous AP, Preethi KC, Kuttan R. Carotenoid lutein protects rats from paracetamol, carbon tetrachloride and ethanol induced hepatic damage. J Pharm Pharmacol. 2010;6:1054-60.
7. Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4:307-20.
8. Chirino YI, Trujillo J, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Bobadilla NA, Pedraza-Chaverri J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett. 2008;176:48-57.
9. Jamieson ER, Lippard SJ. Structure, recognition and processing of cisplatin-DNA adducts. Chem Rev. 1999;99:2467-98.
10. Sastry J, Kellie SJ. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol. 2005;22:441-5.
11. Masuda H, Tanaka T, Takahama U. Cisplatin generates superoxide anionby interaction with DNA in a cell-free system. Biochem Biophys Res Commun. 1994;203:1175-80.
12. Kawai Y, Nakao T, Kunimura N, Khoda Y, Gemba M. Relationship of intracellular calcium and oxygen radicals to cisplatin related renal cell injury. J. Pharmacol Sci. 2006; 100:65-72.
13. Jiang M, Wei Q, Pabla N, Dong G, Wang CY, Yang T, Smith SB, Dong Z. Effects of hydroxyl radical scavenging on cisplatin induced P53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol. 2007;73:1499-510.
14. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265-79.
15. Somani SM, Husain K, Whitworth C. Dosedependent protection by lipoic acid against cisplatin induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol. 2000;86:234-41.
16. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, Cleton FJ, Osanto S. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, doubleblind, placebo-controlled study. Eur J Cancer. 2004;40:1713-23.
17. Chaudhari AR. In: Chaudhari, AR, editor. A text book of practical physiology. Hyderabad, India: PARAS Medical Publisher; 2000. p. 104-8.
18. Drabkin DL, Austin JM. Spectrometric studies; spectrometricconstants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem.1932;98:719-33.
19. Sredni B, Albeck M, Kazimmirsky G, Shalet F. The immunomodulator administered orally as a radioprotective agent. Int J Immunopharmacol. 1992; 14:613-9.
20. Ohkawa H, Oshishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 1979; 95:351-8.
21. Moron MA, De Pierre JW, Manner VB. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat liver. Biochema Biophys Acta. 1979; 582:67-8.
22. Mc Cord JM, Fridovich I. Superoxide dismutase enzyme function for erythrocaprein. J Biochem. 1969;224:6049-56.
23. Aebi H. Catalase estimation. In: Bermeyer, HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 674-84.
24. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-5.
25. Boogaard PJ, Lempers EL, Mulder GJ, Meerman JHN. 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem Pharmacol. 1991;41:1997-2003.
26. Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect. 1994;102:5-12.
27. Yilmaz HR, Iraz M, Sogut S, Ozyurt H, Yildirim Z, Akyol O, Gergerlioglu S. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004;50:287-90.
28. Sharma RP. Interactions of cisplatin with cellular zinc and copperin liver and kidney tissues. Pharmacol Res Commun. 1985; 17:197-206.
29. DeWoskin RS, Riviere JE. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyl dithiocarbamate, but not mesna. Toxicol Appl Pharmacol. 1992; 112:182-9.
30. Rana SVS, Allen T, Singh R. Inevitable glutathione, then and now. Ind J Exp Biol. 2002; 40:706-16.
31. Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. Jam Soc Nephrol. 2003;14:1-10.
32. Sindhu ER, Firdous AP, Ramnath V, Kuttan R. Effect of carotenoid lutien on N-nitrosodiethylamine induiced hepatocellular carcinoma and its mechanism of action. Eur J Cancer Prev. 2012; Nov 25. [Upub ahead of print]
33. Ajith TA, Jose N, Janardhanan KK. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res. 2002;21:487-91.
34. Cetin R, Devrim E, Kilicoglu B, Avei A, Candi O, Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J Appl Toxicol. 2006;26:42-6.
35. Babu E, Gopalkrishnan VK, Sriganth NP, Gopalkrishnan R, Sakthisekharan D. Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem. 1995;144:7-11.
36. Ajith TA, Nivitha V, Usha S. Zingiber officinale Roscoe alone and in combination with a-tocopherol protect the kidney against cisplatin-induced acute renal failure. Food Chem Toxicol. 2007;45:921-7.